Patents by Inventor Ian McNiece

Ian McNiece has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) MESENCHYMAL STEM CELLS FOR THERAPEUTIC APPLICATIONS
    Publication number: 20240082310
    Abstract: The present disclosure provides use of neurokinin 1 receptor (NK1R) as a marker for identifying and/or isolating multipotential cells. The present disclosure provides cell populations enriched by methods of the present disclosure and therapeutic uses of these cells and agents derived from these cells.
    Type: Application
    Filed: March 27, 2023
    Publication date: March 14, 2024
    Inventors: Ian McNiece, Peter Altman
  • FETAL STROMAL CELL DERIVED EXOSOMES FOR TISSUE REPAIR
    Publication number: 20230355652
    Abstract: Cardiac stromal cells produce exosomes containing micro RNAs including: miR1, miR133a, and miR206. These micro RNAs have pivotal roles in development and physiology of muscle tissues including the heart. Exosomes containing these micro RNAs are delivered to result in regeneration of ischemic heart tissue.
    Type: Application
    Filed: June 28, 2023
    Publication date: November 9, 2023
    Inventor: Ian McNiece
  • Bone marrow derived neurokinin-1 receptor positive (NK1R+) mesenchymal stem cells for therapeutic applications
    Patent number: 11642377
    Abstract: The present disclosure provides use of neurokinin 1 receptor (NK1R) as a marker for identifying and/or isolating multipotential cells. The present disclosure provides cell populations enriched by methods of the present disclosure and therapeutic uses of these cells and agents derived from these cells.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: May 9, 2023
    Assignee: BioCardia, Inc.
    Inventors: Ian McNiece, Peter Altman
  • BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) PRECURSOR CELLS FOR THERAPEUTIC APPLICATIONS
    Publication number: 20200101113
    Abstract: The present disclosure provides use of neurokinin 1 receptor (NK1R) as a marker for identifying and/or isolating multipotential cells. The present disclosure provides cell populations enriched by methods of the present disclosure and therapeutic uses of these cells and agents derived from these cells.
    Type: Application
    Filed: September 26, 2019
    Publication date: April 2, 2020
    Inventors: Ian McNiece, Peter Altman
  • METHOD OF GROWTH OF MESENCHYMAL CELLS UNDER NON-ADHERENT CONDITIONS FOR CLINICAL APPLICATIONS
    Publication number: 20100047211
    Abstract: The invention provides methods for expanding mesenchymal stem cells (MSCs) in non-adherent cultures. The methods include the propagation of MSCs in or on non-adherent matrices. The invention further provides administration and the use of cells propagated by the method of the invention for administration and preparation of a therapeutic agent. The invention further provides kits including cells propagated by the methods of the inventions.
    Type: Application
    Filed: May 18, 2007
    Publication date: February 25, 2010
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventor: Ian Mcniece
  • METHOD OF USING STROMA CELLS FROM CORD BLOOD TO EXPAND AND ENGRAFT NUCLEATED CELLS FROM CORD BLOOD
    Publication number: 20100034793
    Abstract: The invention features a method for expanding and engrafting nucleated cells, e.g., progenitor cells, such as hematopoietic cells, obtained from cord blood by co-culturing the nucleated cells with adherent stroma cells, e.g., mesenchymal stem/progenitor cells, also obtained from cord blood.
    Type: Application
    Filed: April 19, 2006
    Publication date: February 11, 2010
    Applicant: The John Hopkins University
    Inventors: Ian McNiece, Jin-Fu Wang